ProShares UltraShort Nasdaq Biotechnology (BIS)

NASDAQ: BIS · Real-Time Price · USD

10.66

+0.12 (1.14%)

At close: Nov 13, 2026, 4:00 PM EST

10.72

+0.06 (0.58%)

After-hours: Nov 13, 2026, 7:30 PM EST

Assets	$1.67M
Expense Ratio	0.95%
PE Ratio	n/a
Forward PE	n/a
Shares Out	165,519
Dividend	$0.62 (5.80%)
Ex-Dividend Date	Sep 23, 2026
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	2,252
Open	10.58
Previous Close	10.54
Day's Range	10.58 - 10.82
52-Week Low	9.92
52-Week High	21.14
Beta	-1.21
Holdings	6
Inception Date	Apr 8, 2010

About BIS

Fund Home Page

The ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity

Category Trading--Inverse Equity

Stock Exchange Nasdaq

Ticker Symbol BIS

ETF Provider ProShares

Index Tracked NASDAQ / Biotechnology

Top Holdings

-199.59% of assets

Name	Symbol	Weight
NET OTHER ASSETS (LIABILITIES)	n/a
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	n/a	-32.01%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	n/a	-32.89%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	n/a	-37.34%
NASDAQ BIO INDEX SWAP BNP PARIBAS	n/a	-44.90%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	n/a	-52.45%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Sep 23, 2026	$0.13889	Sep 29, 2026
Jun 24, 2026	$0.1366	Jun 30, 2026
Mar 25, 2026	$0.13714	Mar 31, 2026
Dec 24, 2025	$0.20514	Dec 31, 2025
Sep 24, 2025	$0.30854	Sep 30, 2025
Jun 25, 2025	$0.2161	Jul 1, 2025

Full Dividend History

Performance

BIS had a total return of -45.59% in the past year, including dividends. Since the fund's inception, the average annual return has been -33.09%.